Vaxart Inc (VXRT) concluded trading on Thursday ata closing price of $0.74, with 7.39 million shares of worth about $5.47 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -37.27% during that period and on August 15, 2024 the price saw a gain of about 25.66%. Currently the company’s common shares owned by public are about 227.44M shares, out of which, 225.47M shares are available for trading.
Stock saw a price change of 17.97% in past 5 days and over the past one month there was a price change of 5.25%. Year-to-date (YTD), VXRT shares are showing a performance of 29.77% which increased to 6.54% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $0.52 but also hit the highest price of $1.54 during that period. The average intraday trading volume for Vaxart Inc shares is 4.07 million. The stock is currently trading 15.35% above its 20-day simple moving average (SMA20), while that difference is up 10.02% for SMA50 and it goes to -11.26% lower than SMA200.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Vaxart Inc (NASDAQ: VXRT) currently have 227.44M outstanding shares and institutions hold larger chunk of about 17.86% of that.
The stock has a current market capitalization of $169.06M and its 3Y-monthly beta is at 0.67. It has posted earnings per share of -$0.46 in the same period. It has Quick Ratio of 4.54 while making debt-to-equity ratio of 0.29. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for VXRT, volatility over the week remained 11.07% while standing at 7.74% over the month.
Stock’s fiscal year EPS is expected to rise by 15.35% while it is estimated to increase by 10.36% in next year.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Oppenheimer on Aug-16-24 offering an Outperform rating for the stock and assigned a target price of $4 to it. Coverage by Jefferies stated Vaxart Inc (VXRT) stock as a Buy in their note to investors on December 29, 2021, suggesting a price target of $12 for the stock. On November 02, 2021, Cantor Fitzgerald Initiated their recommendations, while on June 29, 2021, B. Riley Securities Downgrade their ratings for the stock with a price target of $9. Stock get a Buy rating from Jefferies on June 24, 2021.
